Voyageur Pharmaceuticals Ltd.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$1,399,469 over the previous period. Total operating expenses were $1,220,952.

Profit Margin

Voyageur Pharmaceuticals Ltd. (TSX:VM.V): Profit margin
2014 0 -94.46K
2015 0 -1.48K
2016 0 -52.32K
2017 0 -670.75K
2018 0 -555.86K
2019 0 -552.29K
2020 0 -1.13M
2021 0 -2.05M
2022 0 -1.75M
2023 0 -1.39M

VM.V Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0000000000
Cost of revenue
2.18K2.90K2.24K1.48K2.12K000137.22K0
Gross profit
-2.18K-2.90K-2.24K-1.48K-2.12K000-137.22K0
Operating exp.
Research and development
0527.56K496.51K0000000
Selling and marketing
280.94K52749600000-107.34K0
Total operating expenses
1.22M1.75M2.05M1.00M554.89K866.02K655.74K52.32K1.48K94.46K
Operating income
-1.22M-1.74M-2.05M-848.93K-554.89K-1.14M-615.36K-52.32K-1.48K-94.46K
Other income (expenses), net
-178.51K-1.96K-3.27K-154.83K2.6K310.16K-55.73K000
Income before tax
-1.39M-1.75M-2.05M-1.13M-552.29K-555.86K-670.75K-52.32K-1.48K-94.46K
Income tax expense
01.96K-1152.10K00-40.37K0-246.05K0
Net income
-1.39M-1.75M-2.05M-1.13M-552.29K-555.86K-670.75K-52.32K-1.48K-94.46K
Earnings per share
Basic EPS
-0.01-0.01-0.02-0.01-0.00-0.01-0.01-0.05-0.00-0.09
Diluted EPS
-0.01-0.01-0.02-0.01-0.00-0.01-0.01-0.05-0.00-0.09